|
American Medical Association |
Creating an Ethical Practice Environment: Leadership for Ethical Practice |
0.25 |
Yes |
11/11/2024 |
|
JAMA Neurology |
Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity |
1 |
Yes |
11/11/2024 |
|
American Medical Association |
Ethics Issues in Organ Donation |
1 |
Yes |
11/11/2024 |
|
JAMA Otolaryngology – Head & Neck Surgery |
Evaluation of Levels of Triamcinolone Acetonide in Human Perilymph and Plasma After Intratympanic Application in Patients Receiving Cochlear Implants |
1 |
Yes |
11/11/2024 |
|
JAMA Ophthalmology |
Periorbital Mass in a 44-Year-Old Woman |
1 |
Yes |
11/11/2024 |
|
JAMA Neurology |
Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis |
1 |
Yes |
11/11/2024 |
|
JAMA Neurology |
Acute Myelopathy in a Man With Cutaneous Papules |
1 |
Yes |
11/15/2024 |
|
JAMA |
Pharyngitis and Tonsillar Exudates in an 18-Year-Old Woman |
1 |
Yes |
11/15/2024 |
|
JAMA |
Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction - The PARALLAX Randomized Clinical Trial |
1 |
Yes |
11/16/2024 |
|
JAMA |
Electrodiagnostic Testing for Diagnosing Polyneuropathy |
1 |
Yes |
11/16/2024 |
|
American Medical Association |
Advancing Equity Through Quality and Safety: Five Focus Areas |
0.25 |
Yes |
11/17/2024 |
|
JAMA Ophthalmology |
Association of Reading Performance in Geographic Atrophy Secondary to Age-Related Macular Degeneration With Visual Function and Structural BiomarkersAssociation of Reading Performance in Geographic Atrophy With Visual Function and Structural Biomarkers |
1 |
Yes |
11/17/2024 |
|
American Medical Association |
Developing an Equity Tracker |
0.25 |
Yes |
11/17/2024 |
|
American Medical Association |
Embedding Equity Into Quality, Safety, and Risk Analyses |
0.25 |
Yes |
11/17/2024 |
|
American Medical Association |
Embedding Equity Into Safety Reporting System |
0.25 |
Yes |
11/17/2024 |
|
JAMA Dermatology |
Evaluation of Pharmacologic Treatments for H1 Antihistamine–Refractory Chronic Spontaneous Urticaria |
1 |
Yes |
11/17/2024 |
|
JAMA Ophthalmology |
Health Care Price Transparency in Ophthalmology |
1 |
Yes |
11/17/2024 |
|
American Medical Association |
Panel Discussion: Implementing the Five Focus Areas for Advancing Equity Through Quality and Safety |
0.75 |
Yes |
11/17/2024 |
|
JAMA Ophthalmology |
An Atypical Case of Optic Neuropathy |
1 |
Yes |
11/18/2024 |
|
JAMA Oncology |
Neoadjuvant Endocrine Therapy in Clinical Practice |
1 |
Yes |
11/18/2024 |
